Wednesday, June 10, 2026

pharma Β· Hepatitis B Β· Mixed Dyslipidemia Β· ARWR

Arrowhead Pharmaceuticals Ireland

Arrowhead Pharmaceuticals Ireland clinical programs β€” 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

177 E Colorado Blvd, Suite 700, Pasadena, California 91105, US HQ
746 Employees
Public company Type
ARWR Β· NYSE Ticker
Company details
Intelligence Β· Clinical Programs

Arrowhead Pharmaceuticals Ireland projects

13 ClinicalTrials.gov programs sponsored by Arrowhead Pharmaceuticals Ireland.

Arrowhead Pharmaceuticals Ireland has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ARC-520

    Arrowhead Pharmaceuticals Ireland Limited

    Healthy

    phase 1 small molecule completed

    2 trials
  2. ARC-521 Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Hepatitis B

    phase 1 small molecule terminated

    1 trial
  3. ARO-AAT Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Alpha 1-Antitrypsin Deficiency

    phase 1 small molecule completed

    1 trial
  4. ARO-ANG3

    Arrowhead Pharmaceuticals Ireland Limited

    Dyslipidemias

    phase 1 small molecule completed

    1 trial
  5. ARO-APOC3

    Arrowhead Pharmaceuticals Ireland Limited

    Hypertriglyceridemia

    phase 1 small molecule completed

    1 trial
  6. ARO-ATXN2 Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Spinocerebellar Ataxia Type 2

    phase 1 small molecule active

    1 trial
  7. ARO-CFB

    Arrowhead Pharmaceuticals Ireland Limited

    IgA Nephropathy

    phase 1 small molecule completed

    1 trial
  8. ARO-HIF2

    Arrowhead Pharmaceuticals Ireland Limited

    Clear Cell Renal Cell Carcinoma

    phase 1 small molecule completed

    1 trial
  9. ARO-RAGE Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Asthma

    phase 1 small molecule completed

    1 trial
  10. ARO-SOD1 Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule terminated

    1 trial
  11. Azithromycin Pill

    Arrowhead Pharmaceuticals Ireland Limited

    Infections

    phase 1 small molecule active

    1 trial
  12. Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

    Arrowhead Pharmaceuticals Ireland Limited

    spinocerebellar ataxia type 2

    phase 1 other active

    1 trial
  13. VSA001 injection

    Arrowhead Pharmaceuticals Ireland Limited

    Healthy Adult Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Arrowhead Pharmaceuticals Ireland have?

13 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.